In 1994, CMS published an NCD called Platelet-Derived Wound Healing Formula (CIM 45-26) based on the Agency’s evaluation of Procuren™. The determination was for national non-coverage.
Subsequently, other blood-derived products have been used to treat wounds and confusion has arisen both among CMS contractors and the medical community as to their inclusion under CIM 45-26. CMS has determined that opening an NCD will facilitate updating this topic with more recent evidence and a more complete listing of affected products.
Opened formal NCD request and posted tracking sheet on the Internet. CMS is investigating the processes that utilize blood-derived products for the healing of chronic wounds. We are requesting comments on similar products available.
Additional Lead Analyst: Betty Shaw, 410-786-4165